Spectrum Pharmaceuticals buy krebskrebs
Start price
23.08.21
/
50%
€2.01
Target price
23.08.22
€3.00
Performance (%)
-34.26%
End price
24.08.22
€1.32
Summary
This prediction ended on 24.08.22 with a price of €1.32. Massive losses of -34.26% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Spectrum Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by krebskrebs for this prediction
In the thread Spectrum Pharmaceuticals diskutieren
In the thread Trading Spectrum Pharmaceuticals
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten